Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain): Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España).
Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain): Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España).
复制标题
DOI:
10.1016/j.medcle.2020.06.017
复制
发表时间:
2020-10-23
期刊:
影响因子:
--
通讯作者:
Marzo Sola ME
中科院分区:
文献类型:
--
作者:
Castillo Álvarez F;López Pérez MÁ;Marzo Sola ME
We analysed general consultations due to their greater volume (1339 patients), differentiating two tasks: first visits (315 patients) and follow-up visits (1024 patients). Of the first-visit patients, 18.1% were referred for a follow-up, 16.2% were resolved and 65. 7% required a face-to-face visit. Of the follow-up group, 74.6% were doing a check-up, 25.3% were resolved and only 0.1% required a face-to-face visit.Despite the technical limitations, the percentage of resolutions of first-visit patients was not negligible (34.3%) but without a doubt, what was striking was the resolution capacity of almost 100% of the patients in the follow-up group. This data led us to perform a comparative analysis with the face-to-face model of 1023 review patients seen in the 7 weeks prior to the start of the teleconsultation model. Of these 1023 patients seen in person, 237 (23.2%) were resolved and 786 (76.8%) went for a follow-up visit (Table 1). We did not observe statistically significant differences in the outcomes of the follow-up group when the face-to-face model was compared to teleconsultation (p= 0.262).